Disqus Shortname

Breaking News

Home / News18 / Top India News- News18.com / Johnson & Johnson in Talks With India for Clinical Study Of Single-Dose Covid-19 Vaccine

Johnson & Johnson in Talks With India for Clinical Study Of Single-Dose Covid-19 Vaccine

أبريل 09, 2021 ,
The J&J vaccine Phase 3 data shows it is 85% effective in preventing severe disease and 66% to 72% effective in preventing 'moderate to severe' COVID-19 infection.

from Top India News- News18.com https://ift.tt/3dPNPlo
via IFTTT

ليست هناك تعليقات

الاشتراك في: تعليقات الرسالة ( Atom )